Search results
Vaccines deployed against triple viral threat from COVID-19, RSV, flu
Detroit Free Press via Yahoo News· 9 months agoNewly formulated COVID-19 vaccines won final approval from federal regulators Tuesday, giving...
California's COVID comeback intensifies, but officials say there's no cause for alarm
LA Times via Yahoo News· 9 months agoLunch time crowd at Grand Central Market in Los Angeles. Coronavirus levels have more than doubled...
'Excess deaths' tied to COVID have plummeted in America — what does that mean?
Live Science via Yahoo News· 11 months agoA woman wearing blue latex gloves administering a vaccine to a man During the worst waves of the...
The Most Common Questions About The Updated COVID Vaccine, Answered
HuffPost Life via Yahoo News· 2 years agoExperts break down the most important information on the new bivalent COVID-19 shots, which are now...
Pfizer Slashed Its Guidance, but Is It Still a Smart Long-Term Buy?
Motley Fool via Yahoo Finance· 6 months agoPer updated guidance for its upcoming 2024 fiscal year, issued on Dec. 13, Pfizer (NYSE: PFE) has a...
FDA to okay second omicron-targeting booster for some, officials say
Washington Post via Yahoo News· 1 year agoFederal regulators have decided to authorize a second omicron-specific coronavirus vaccine booster...
Where to get your COVID-19 bivalent booster vaccine in Michigan
Detroit Free Press via Yahoo News· 2 years agoThe newly authorized COVID-19 bivalent vaccine booster shots aimed at the BA.4 and BA.5 omicron...
Gap between tax expected and paid at £32bn in 2020/21 – HMRC
The Independent via Yahoo News· 2 years agoThe tax gap – the difference between the total amount of tax expected and that which is actually...
2 Stocks Down 36% or More to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 4 months agoThere's arguably no better time to buy a stock than when it's been beaten down. Doing so provides a...
Pfizer's Heading for a Patent Cliff. Is the Stock Still a Buy?
Motley Fool· 1 year agoThe company also continues to benefit from sales of blockbusters including blood thinner Eliquis and...